TITLE

New protocol may improve rare pediatric brain cancer survival

AUTHOR(S)
Haigh, Christen
PUB. DATE
November 2009
SOURCE
Hem/Onc Today;11/10/2009, Vol. 10 Issue 21, p25
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses a study about new standard treatment for choroid plexus tumors presented by Johannes Wolff of the University of Texas during the 41st Annual Meeting of the International Society of Pediatric Oncology.
ACCESSION #
44861393

 

Related Articles

  • A REVIEW OF PAROTID GLAND TUMOURS IN PORT HARCOURT, NIGERIA. ONOTAI, LUCKY OBUKOWHO; OPARA, KINGSLEY // Online Journal of Otolaryngology;2015, Vol. 5 Issue 4, p109 

    BACKGROUND: Among salivary gland tumors, 80% arise in the parotid glands. Parotid tumors pose a challenge to most surgeons both in diagnosis and treatment. This study evaluates the clinical profile and management outcomes of parotid gland tumors in Port Harcourt, Nigeria. MATERIALS AND METHODS:...

  • Trials backing cancer treatments said to be absent.  // Medical Device Daily;6/5/2013, Vol. 17 Issue 108, Special section p2 

    The article reports on a statement by the University of North Carolina Lineberger Comprehensive Cancer Center that the body of randomized, controlled trials (RCTs) is inadequate to support several uses of the current suite of cancer therapies.

  • Tumor gene medicine. Frederickson, Robert // Nature Biotechnology;Apr99, Vol. 17 Issue 4, p318 

    Presents an alternative developed by scientists for the treatment of tumors. Details of the treatment; Conventional drugs that inhibit tumor growth; Scientists that developed the alternative.

  • Interdependencies among clinical research funders. Hobbs, F. D. Richard // BMJ: British Medical Journal;8/23/2014, Vol. 349 Issue 7972, pg4892 

    The author discusses the economic condition in Great Britain wherein the government made a deep cut for the public spending to reduce budget deficiency for the healthcare services. He highlights the importance of medical research in the country especially on cancer research to meet the demand of...

  • Cancer biology: Immunity let loose.  // Nature;6/13/2013, Vol. 498 Issue 7453, p140 

    The article focuses on a research conducted by the Antoni Ribas, a researcher at the University of California in Los Angeles, California that found tumours shrank by at least 30 percent in people with advanced melanoma treated with lambrolizumab, a compound that blocks a checkpoint inhibitor PD-1.

  • Stereotactic irradiation of glomus jugulare tumors: does the previous embolization matter? Zolotova, S.; Galkin, M.; Vetlova, E.; Filchenkova, N.; Antipina, N.; Schurova, I.; Shelesko, E.; Zinkevich, D.; Golanov, A. // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p124 

    Object: Glomus tumors account for 0.6% of head and neck tumors and 80% of jugular foramen tumors. Because of the highly vascular nature and relatively inaccessible anatomical location of glomus jugulare tumors, their excision is often problematic and stays very challenging for neurosurgeons. The...

  • Guess Who's Coming to Dinner? Innate Immunity!  // BioWorld Today;4/2/2012, Vol. 23 Issue 63, Special section p1 

    The article focuses on a study by scientists from Stanford University which described an antibody that was effective in treating various solid tumours.

  • Partial Nephrectomy Is An Option for Larger Tumors.  // Renal & Urology News;Jun2012, Vol. 11 Issue 6, p30 

    The article focuses on a study regarding the safety of the use of partial nephrectomy (PN) on patients with renal tumors that are seven centimeter (cm) or more in diameter.

  • Oncogene: Scientists aim to kill lung tumors.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article informs that scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that can be used to kill lung tumors.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics